Clinical Roundup Novel tumor models provide insights into deadly sarcomas September 20, 2024Vol.50 No.35
Clinical Roundup Combination therapy shows reduced agitated delirium in patients with advanced cancers September 20, 2024Vol.50 No.35
Clinical Roundup Incyte’s CDK2 inhibitor shows evidence of clinical activity in treating advanced solid tumors, notably ovarian cancer September 20, 2024Vol.50 No.35
Clinical Roundup NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry September 20, 2024Vol.50 No.35
Clinical Roundup Wistar Institute researchers identify the role of a Parkinson’s disease-related protein in cancer and T-cell activation September 20, 2024Vol.50 No.35
Clinical Roundup Friends of Cancer Research announces publication focused on enhancing clinical trials with pragmatic trial elements September 13, 2024Vol.50 No.34
Clinical Roundup DNA methylation contributes to 9/11-related breast cancers September 13, 2024Vol.50 No.34
Clinical Roundup Immunotherapy before and after lung cancer surgery reduces death risk, disease recurrence September 13, 2024Vol.50 No.34
Clinical Roundup Dysfunctional white blood cells linked to heightened melanoma risk September 13, 2024Vol.50 No.34
